CN113455656A - Emulsified composition - Google Patents
Emulsified composition Download PDFInfo
- Publication number
- CN113455656A CN113455656A CN202110338259.7A CN202110338259A CN113455656A CN 113455656 A CN113455656 A CN 113455656A CN 202110338259 A CN202110338259 A CN 202110338259A CN 113455656 A CN113455656 A CN 113455656A
- Authority
- CN
- China
- Prior art keywords
- ginseng
- panax
- less
- ginseng seed
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 235000008434 ginseng Nutrition 0.000 claims abstract description 200
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 196
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 190
- 239000000284 extract Substances 0.000 claims abstract description 85
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 73
- 239000000839 emulsion Substances 0.000 claims abstract description 6
- 240000004371 Panax ginseng Species 0.000 claims description 199
- 235000002789 Panax ginseng Nutrition 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 235000013325 dietary fiber Nutrition 0.000 claims description 23
- 229920002148 Gellan gum Polymers 0.000 claims description 17
- 235000010492 gellan gum Nutrition 0.000 claims description 17
- 239000000216 gellan gum Substances 0.000 claims description 17
- 235000002791 Panax Nutrition 0.000 claims description 12
- 241000208343 Panax Species 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 9
- 229920000297 Rayon Polymers 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 8
- 241000207199 Citrus Species 0.000 claims description 7
- 235000020971 citrus fruits Nutrition 0.000 claims description 7
- 229920002907 Guar gum Polymers 0.000 claims description 6
- 241000168720 Panax japonicus Species 0.000 claims description 6
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 6
- 240000005373 Panax quinquefolius Species 0.000 claims description 6
- 241001527087 Panax vietnamensis Species 0.000 claims description 6
- 235000017726 Panax vietnamensis Nutrition 0.000 claims description 6
- 240000004584 Tamarindus indica Species 0.000 claims description 6
- 235000004298 Tamarindus indica Nutrition 0.000 claims description 6
- 229920001525 carrageenan Polymers 0.000 claims description 6
- 235000010417 guar gum Nutrition 0.000 claims description 6
- 239000000665 guar gum Substances 0.000 claims description 6
- 229960002154 guar gum Drugs 0.000 claims description 6
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 6
- 229940082509 xanthan gum Drugs 0.000 claims description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 235000010489 acacia gum Nutrition 0.000 claims description 5
- 235000010418 carrageenan Nutrition 0.000 claims description 5
- 229920000161 Locust bean gum Polymers 0.000 claims description 4
- 235000010420 locust bean gum Nutrition 0.000 claims description 4
- 239000000711 locust bean gum Substances 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 3
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 3
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 229920002752 Konjac Polymers 0.000 claims description 3
- 240000003183 Manihot esculenta Species 0.000 claims description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 3
- 239000004368 Modified starch Substances 0.000 claims description 3
- 229920000881 Modified starch Polymers 0.000 claims description 3
- 235000003174 Panax japonicus Nutrition 0.000 claims description 3
- 241000180664 Panax wangianus Species 0.000 claims description 3
- 235000003138 Panax wangianus Nutrition 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 3
- 235000010419 agar Nutrition 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000000252 konjac Substances 0.000 claims description 3
- 235000010485 konjac Nutrition 0.000 claims description 3
- 235000019426 modified starch Nutrition 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 241000238814 Orthoptera Species 0.000 claims description 2
- 235000004449 Panax japonicus var bipinnatifidus Nutrition 0.000 claims description 2
- 241000190702 Panax japonicus var. bipinnatifidus Species 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 241001625498 Polyscias elegans Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 235000019198 oils Nutrition 0.000 abstract description 22
- 239000002552 dosage form Substances 0.000 abstract description 8
- 241000208340 Araliaceae Species 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 description 24
- 239000003921 oil Substances 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 18
- 238000000605 extraction Methods 0.000 description 17
- 239000012071 phase Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 14
- 239000008213 purified water Substances 0.000 description 14
- 229930182494 ginsenoside Natural products 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 230000037149 energy metabolism Effects 0.000 description 9
- 229940089161 ginsenoside Drugs 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 6
- 229960002297 fenofibrate Drugs 0.000 description 6
- 210000003470 mitochondria Anatomy 0.000 description 6
- 230000002438 mitochondrial effect Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 102000023984 PPAR alpha Human genes 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 101001123331 Homo sapiens Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Proteins 0.000 description 3
- 102100028960 Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Human genes 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000663 muscle cell Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000001493 Cyclophilins Human genes 0.000 description 2
- 108010068682 Cyclophilins Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- AGBCLJAHARWNLA-DQUQINEDSA-N Ginsenoside Rg2 Natural products O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@@](C)(O)CCC=C(C)C)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O AGBCLJAHARWNLA-DQUQINEDSA-N 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010028924 PPAR alpha Proteins 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 101150080431 Tfam gene Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000003416 augmentation Effects 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 238000010805 cDNA synthesis kit Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229940107131 ginseng root Drugs 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000003098 myoblast Anatomy 0.000 description 2
- 210000000107 myocyte Anatomy 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- PUIBPGHAXSCVRF-QHFGJBOXSA-N prostaglandin C1 Chemical compound CCCCC[C@H](O)\C=C\C1=CCC(=O)[C@@H]1CCCCCCC(O)=O PUIBPGHAXSCVRF-QHFGJBOXSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- AGBCLJAHARWNLA-UHFFFAOYSA-N (20R)-ginsenoside Rg2 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C3C(C)(C)C(O)CCC3(C)C3C(C4(CCC(C4C(O)C3)C(C)(O)CCC=C(C)C)C)(C)C2)OC(CO)C(O)C1O AGBCLJAHARWNLA-UHFFFAOYSA-N 0.000 description 1
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 1
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 102000004539 Acyl-CoA Oxidase Human genes 0.000 description 1
- 108020001558 Acyl-CoA oxidase Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 101000833903 Arabidopsis thaliana Acyl-coenzyme A oxidase 2, peroxisomal Proteins 0.000 description 1
- 101000720387 Arabidopsis thaliana Peroxisomal acyl-coenzyme A oxidase 1 Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102100024853 Carnitine O-palmitoyltransferase 2, mitochondrial Human genes 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 101000785223 Crocosmia x crocosmiiflora Myricetin 3-O-glucosyl 1,2-rhamnoside 6'-O-caffeoyltransferase AT1 Proteins 0.000 description 1
- 101000833900 Cucurbita maxima Acyl-coenzyme A oxidase, peroxisomal Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 101000859570 Homo sapiens Carnitine O-palmitoyltransferase 1, liver isoform Proteins 0.000 description 1
- 101000909313 Homo sapiens Carnitine O-palmitoyltransferase 2, mitochondrial Proteins 0.000 description 1
- 101000989606 Homo sapiens Cholinephosphotransferase 1 Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 102000008200 Uncoupling Protein 3 Human genes 0.000 description 1
- 108010021098 Uncoupling Protein 3 Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000678 effect on lipid Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 1
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 1
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 1
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000874 microwave-assisted extraction Methods 0.000 description 1
- JURZHOVRCOWZFN-UHFFFAOYSA-N notoginsenoside R1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(COC7OCC(O)C(O)C7O)C(O)C(O)C6O)C JURZHOVRCOWZFN-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 1
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 1
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940033203 vitamin b6 0.5 mg Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/272—Gellan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
- Jellies, Jams, And Syrups (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The present disclosure relates to an emulsified composition comprising ginseng seed oil and ginseng seed extract, the composition being a single phase. In the case of the composition containing ginseng seed oil as a main component, which is a conventional water-soluble component, there is a problem in that the ginseng seed oil as an oil and fat component is separated from the water-soluble component, thereby lowering the stability of the dosage form, but the emulsion composition according to the present disclosure has excellent stability because the ginseng seed oil as an oil and fat component and the water-soluble component are uniformly mixed, and thus the ginseng seed oil and the water-soluble component are not separated for a long time.
Description
Technical Field
The present disclosure relates to an emulsified composition containing ginseng seed oil and ginseng seed extract.
Background
Ginseng belongs to the genus panax of the family araliaceae, and has been used as a crude drug for the purpose of preventing diseases and prolonging life in korea, china, japan, and the like since more than 2000 years ago. The hitherto known effects and effects of ginseng are an effect on the central nervous system, an anticancer effect and anticancer activity, an immune function regulating effect, an anti-diabetic effect, a liver function hyperfunction effect, an improvement in cardiovascular disorders and an anti-arteriosclerosis effect, a blood pressure regulating effect, an improvement in climacteric disorders and an effect affecting osteoporosis, an anti-stress and anti-fatigue effect, an antioxidant activity, an anti-aging effect and the like. Ginsenosides, which are representative physiologically active ingredients of ginseng, are uniformly distributed in the above-ground and underground parts of ginseng, and a considerable amount of ginsenosides is also distributed in ginseng seeds.
Many studies have been made on the main components and pharmacological actions of ginseng, and it is expected that various adult diseases can be prevented and the possibility of onset can be reduced when ginseng is taken for a long time in consideration of the pharmacological effects of ginseng.
However, in the case of ginseng seed oil or a composition containing ginseng seed oil as a main component, it is difficult to take the composition because of the greasy feeling of oil, and therefore, it can be taken only as a capsule dosage form. In addition, when ginseng seed oil is contained as a main component containing a water-soluble component, there is a problem that ginseng seed oil as an oil component is separated from the water-soluble component, and the stability of the product is lowered.
Disclosure of Invention
In one aspect, the present invention provides a stable emulsified composition in which ginseng seed oil as an oil and fat component is uniformly mixed with a water-soluble component.
In one aspect, the present invention provides an emulsified composition comprising ginseng seed oil and ginseng seed extract.
In an exemplary embodiment, the emulsified composition is a single phase.
In an exemplary embodiment, it may be that the ginseng includes one or more selected from the group consisting of Korean ginseng (Panax ginseng), American ginseng (Panax quinquefolia), Panax notoginseng (Panax notogeng), Vietnamese ginseng (Panax vietnamensis), Panax japonicus (Panax japonica), Korean ginseng (Panax elegator), Panax quinquefolius (Panax wangianus), Panax pinnatifida (Panax bipinnatidifus) and pseudoginseng (Panax pseudoginseng).
In an exemplary embodiment, the ginseng seed extract may be water, C1-C6Ethanol or a mixed solvent thereof.
In an exemplary embodiment, the composition may include 0.001 wt% to 70 wt% of the ginseng seed oil, relative to the total weight of the composition.
In an exemplary embodiment, the composition may include 0.01 wt% to 60 wt% of the ginseng seed extract, relative to the total weight of the composition.
In an exemplary embodiment, the ginseng seed oil and the ginseng seed extract may be in a weight ratio of 1:2 to 1: 100.
In an exemplary embodiment, the composition may contain viscose and dietary fiber.
In an exemplary one embodiment, it may be that the viscose includes one or more selected from the group consisting of Xanthan gum (Xanthan gum), carrageenan (carageenans gum), Guar gum (Guar gum), Gellan gum (Gellan gum), Locust Bean gum (Locust Bean gum), Tamarind gum (Tamarind gum), gum Arabic (Arabic gum), konjac, pectin, agar, tapioca starch, dextrin, Hydroxypropylmethylcellulose (HPMC), sodium alginate, and modified starch.
In an exemplary embodiment, it may be that the dietary fiber contains one or more selected from the group consisting of citrus dietary fiber and wheat dietary fiber.
In one aspect, the composition according to the present invention has ginseng seed oil as an oil and fat component uniformly mixed with a water-soluble component, so that the ginseng seed oil and the water-soluble component are not separated for a long time, and thus is excellent in stability.
Drawings
Fig. 1 is a graph comparing emulsion stability of example 1 and comparative example 1 according to an aspect of the present disclosure.
Fig. 2 is a graph comparing emulsion stability of example 2 and comparative example 2 according to an aspect of the present disclosure.
Fig. 3A to 3F are graphs illustrating an intra-myocyte energy metabolism promoting effect of ginseng seed oil and ginseng seed extract according to an aspect of the present disclosure.
Fig. 4A and 4B are graphs illustrating a synergistic effect of mitochondrial generation of ginseng seed oil and ginseng seed extract according to an aspect of the present disclosure.
Detailed Description
The present invention is described in detail below.
In one aspect, the present disclosure provides an emulsified composition containing ginseng seed oil and ginseng seed extract. In the embodiments of the present disclosure, the composition contains ginseng seed oil and ginseng seed extract, thereby preventing separation of ginseng seed oil and water-soluble components, which are oil and fat components, and thus can provide a stable emulsified composition.
In one embodiment, the emulsified composition may be a single phase. In the present specification, "single phase" means that an oil phase and an aqueous phase are not separated but remain as one phase in an emulsified composition.
The "oil phase" is a phase that is not easily mixed with an aqueous phase, and may be an oil, an organic solvent, a mixture thereof, or the like as a liquid at room temperature and atmospheric pressure. The "water phase" is not limited as long as it is a phase that is not easily mixed with an oil phase and allows the water-soluble polymer to be easily dissolved. For example, water such as purified water or distilled water, polyhydric alcohol, and the like can be included.
In one embodiment, the ginseng may include one or more selected from the group consisting of Korean ginseng (Panax ginseng), American ginseng (Panax quinfolia), Panax notoginseng (Panax notogeng), Vietnamese ginseng (Panax vietnamensis), Panax japonicus (Panax japonica), Korean ginseng (Panax elegator), Panax quinquefolius (Panax wangianus), Panax notoginseng (Panax bipinnatifidus), and Panax pseudoginseng (Panax pseudo-ginseng), but not limited thereto.
In the present specification, as a method for obtaining the "ginseng seed oil", a squeezing method, a supercritical extraction method, a subcritical extraction method, a microwave extraction method, an ultrasonic extraction method, and the like may be used, but the method is not limited as long as it is obvious to those skilled in the art. The ginseng seeds used in the production of the ginseng seed oil of the present specification include all of the germinated or non-germinated ginseng seeds such as dehisced ginseng seeds, and may be fresh ginseng seeds, or ginseng seeds dried by sunlight drying or hot air drying. For example, in the case of the pressing method, ginseng seed oil can be obtained by placing ginseng seeds or ginseng seed powder in an oil press, which can be used without limitation as long as the oil press is used for food, and pressing the ginseng seeds or ginseng seed powder at normal temperature (about 15 ℃ to 25 ℃) for 3 minutes to 20 minutes. In the supercritical extraction method, ginseng seeds or ginseng seed powder may be placed in a supercritical extraction tank, 50mL to 1L of an extraction solvent is added to 1g of ginseng seed powder, and then a supercritical fluid (e.g., carbon dioxide) is supplied, and then the pressure in the extraction tank is maintained at 300bar to 500bar for extraction for 3 hours to 4 hours.
In one embodiment, the ginseng seed oil may be subjected to a purification process as needed. The purification process is not particularly limited, and any method known in the art may be used. For example, the solvent may be removed by filtration under reduced pressure, ion exchange resin chromatography or silica gel column chromatography, and freeze-drying or concentration.
In the present specification, "ginseng seed" may refer to a fruit obtained during the growth of ginseng. Specifically, it may refer to ginseng that grows from 3 to 5 years, more specifically, fruits that bear fruit for about one week in the middle 7 months among ginseng that grows from 4 years. The method of starting the ginseng used in the present specification is not limited, and the ginseng can be cultivated or purchased in the market. The ginseng seed contains more mineral components including vitamins and ginsenoside than the commonly used ginseng root, and particularly, the ginsenoside contained in the ginseng seed has completely different components from the ginseng root. More specifically, the ginseng seeds contain more PT (Protopanaxatriol) ginsenoside including ginsenoside Re, Rg1, Rg2 and the like than PD (Protopanaxadiol) ginsenoside including ginsenoside Rb1, Rb2, Rc, Rd and the like, and thus can exhibit remarkably superior effects than the ginseng roots.
In the present specification, the "ginseng seed extract" is a broad concept including the following regardless of the extraction method, the extraction solvent, the extracted components, or the form of the extract: the substances obtained by extracting the components of ginseng seeds are all included and include substances obtained by an extraction method including a process of treatment with heat, acid (acid), base (base), enzyme, etc. in the process of extracting the components, and substances obtained by extracting the components of ginseng seeds and then processing or treating them by other methods are all included. Specifically, the processing or treatment may be further fermentation or enzyme treatment of the ginseng seed extract. Therefore, the ginseng seed extract of the present specification may be a fermented product. In the present specification, the ginseng seed extract may be an extract of the following ginseng seeds, specifically, an extract of fresh ginseng seeds or an extract of dried ginseng seeds. In the present specification, fresh ginseng seeds, dried ginseng seeds, or other processed products of ginseng seeds (for example, fermented products, dried pulverized products, etc.) that can be used for the extraction process may be similar or identical in composition to each other. Therefore, fresh ginseng seeds or dried ginseng seeds or other processed products of ginseng seeds having similar or identical components may also exhibit the effects and uses of the ginseng seed extract disclosed in the present specification.
In the present specification, the extraction method for obtaining the "ginseng seed extract" may be heating extraction, cold-soaking extraction, reflux-cooling extraction, ultrasonic extraction, or the like, but is not limited as long as it is an extraction method apparent to those skilled in the art. The ginseng seed used for preparing the ginseng seed extract of the present specification may be a dried ginseng seed, a fresh ginseng seed fruit, or a ginseng seed powder, and any material may be used without limitation as long as it is prepared from a fresh ginseng seed fruit. The ginseng seed extract of the present specification may be an extract of water, an organic solvent or a mixed solvent thereof. The organic solvent may be C1-C6Ethanol, acetone, hexane, ethyl acetate, carbon dioxide, or a mixed organic solvent of two or more thereof, but is not limited thereto. The ginseng seed extract of the present specification further contains a substance obtained by concentrating under reduced pressure the extract obtained by the extraction with the extraction solvent. The concentration under reduced pressure may be specifically carried out at 35 ℃ to 50 ℃, but is not limited thereto. When the concentration under reduced pressure is performed at a temperature within the above range, the synergistic effect of the various components in the ginseng seed extract of the present invention is excellent. From the above-mentioned viewpoints, the concentration under reduced pressure may be carried out specifically under conditions of 36 ℃ or higher, 37 ℃ or higher, 38 ℃ or higher, 39 ℃ or higher, 40 ℃ or higher, 41 ℃ or higher, 42 ℃ or higher, and/or 49 ℃ or lower, 48 ℃ or lower, 47 ℃ or lower, 46 ℃ or lower, 45 ℃ or lower, 44 ℃ or lower, and 43 ℃ or lower. The concentration under reduced pressure may be specifically performed under conditions of 600mmHg or more, 620mmHg or more, 640mmHg or more, 650mmHg or more, 660mmHg or more, 680mmHg or more, 700mmHg or more, 720mmHg or more, 740mmHg or more, and/or 760mmHg or less, 740mmHg or less, 720mmHg or less, 700mmHg or less, 680mmHg or less, 660mmHg or less, 650mmHg or less, 640mmHg or less, 620mmHg or less, and 600mmHg or less.
In one embodiment, the composition may contain 0.001 wt% to 70 wt% of the ginseng seed oil, relative to the total weight of the composition. When the ginseng seed oil is contained in an amount exceeding 70% by weight, the stability of the composition may be reduced. Specifically, the composition may contain 0.001% by weight or more, 0.002% by weight or more, 0.003% by weight or more, 0.005% by weight or more, 0.007% by weight or more, 0.01% by weight or more, 0.02% by weight or more, 0.03% by weight or more, 0.05% by weight or more, 0.07% by weight or more, 0.1% by weight or more, 0.2% by weight or more, 0.3% by weight or more, 0.5% by weight or more, 0.7% by weight or more, 1% by weight or more, 1.1% by weight or more, 1.2% by weight or more, 1.3% by weight or more, 1.4% by weight or more, 1.5% by weight or more, 2% by weight or more, 3% by weight or more, 4% by weight or more, 5% by weight or more, 6% by weight or more, 7% by weight or more, 8% by weight or more, 9% by weight or more, 10% by weight or more, 12% by weight or more, 13% by weight or more, or 15% by weight or more, or 13% by weight or more, 70 wt% or less, 69 wt% or less, 68 wt% or less, 67 wt% or less, 66 wt% or less, 65 wt% or less, 64 wt% or less, 63 wt% or less, 62 wt% or less, 61 wt% or less, 60 wt% or less, 59 wt% or less, 58 wt% or less, 57 wt% or less, 56 wt% or less, 55 wt% or less, 54 wt% or less, 53 wt% or less, 52 wt% or less, 51 wt% or less, 50 wt% or less, 49 wt% or less, 48 wt% or less, 47 wt% or less, 46 wt% or less, 45 wt% or less, 44 wt% or less, 43 wt% or less, 42 wt% or less, 41 wt% or less, or 40 wt% or less of the ginseng seed oil.
In one embodiment, the composition may contain 0.01 wt% to 60 wt% of the ginseng seed extract, relative to the total weight of the composition. When the ginseng seed extract is contained in an amount exceeding 60% by weight, the flowability is poor, which may cause inconvenience in the production process. Specifically, the composition may contain 0.01 wt% or more, 0.02 wt% or more, 0.03 wt% or more, 0.05 wt% or more, 0.07 wt% or more, 0.1 wt% or more, 0.2 wt% or more, 0.3 wt% or more, 0.5 wt% or more, 0.7 wt% or more, 1 wt% or more, 2 wt% or more, 3 wt% or more, 5 wt% or more, 7 wt% or more, 9 wt% or more, 10 wt% or more, 11 wt% or more, 12 wt% or more, 13 wt% or more, 14 wt% or more, 15 wt% or more, 16 wt% or more, 17 wt% or more, 18 wt% or more, 19 wt% or more, or 20 wt% or more, and 60 wt% or less, 59 wt% or less, 58 wt% or less, 57 wt% or less, 56 wt% or less, 54 wt% or less, 53 wt% or less, or more, The ginseng seed extract is 52 wt% or less, 51 wt% or less, 50 wt% or less, 48 wt% or less, 46 wt% or less, 44 wt% or less, 42 wt% or less, or 40 wt% or less.
In one embodiment, the weight ratio of the ginseng seed oil and the ginseng seed extract may be 1:2 to 1:100, or 1:2 to 1:50, or 1:2 to 1:15, or 1:7 to 1:13, or 1: 10. When the weight ratio of the ginseng seed oil to the ginseng seed extract exceeds the above range, the oil layer may be separated, thereby reducing the dosage form stability.
In one embodiment, the composition is free of other surfactants. The present disclosure substantially provides an emulsified composition that is stably dispersible without a surfactant. The term "substantially free of surfactant" means that the amount of surfactant in the synthetic ingredients can be minimized or completely free of surfactant, and means that the surfactant is contained in an amount of 1% or less, preferably 0.5% or less, preferably 0.1% or less, and more preferably 0.01% or less, based on the total weight of the composition.
In one embodiment, the composition may further comprise viscose (gum) and dietary fiber.
In one embodiment, the viscose may contain one or more selected from the group consisting of Xanthan gum (Xanthan gum), carrageenan (Carrageenans gum), Guar gum (Guar gum), Gellan gum (Gellan gum), Locust Bean gum (locusts Bean gum), Tamarind gum (Tamarind gum), gum Arabic (arabitic gum), konjac, pectin, agar, tapioca starch, dextrin, Hydroxypropylmethylcellulose (HPMC), sodium alginate, and modified starch.
In one embodiment, the composition may contain from 0.001% to 5% by weight of the viscose, relative to the total weight of the composition. When the viscose is contained in an amount exceeding 5% by weight, a large amount of foam is generated and may cause discomfort in swallowing the composition when it is drunk. Specifically, the composition may contain 0.001 wt% or more, 0.002 wt% or more, 0.003 wt% or more, 0.005 wt% or more, 0.007 wt% or more, 0.01 wt% or more, 0.02 wt% or more, 0.03 wt% or more, 0.04 wt% or more, 0.05 wt% or more, 0.06 wt% or more, 0.07 wt% or more, 0.08 wt% or more, 0.09 wt% or more, or 0.1 wt% or more, and 5 wt% or less, 4.9 wt% or less, 4.8 wt% or less, 4.7 wt% or less, 4.6 wt% or less, 4.5 wt% or less, 4.4 wt% or less, 4.3 wt% or less, 4.2 wt% or less, 4.1 wt% or less, 4 wt% or less, 3.9 wt% or less, 3.8 wt% or less, 3.5 wt% or less, 3.4.4 wt% or less, 3.3.3 wt% or less, 3.1 wt% or less, 3.3 wt% or less, 3.3.3 wt% or less, 3.1 wt% or less, 3.9 wt% or less, 3.3.3.3 wt% or less, 3.1 wt% or less, 3.3.3.1 wt% or less, 3 or less, 3.3.1 wt% or less, 3 or less, 3.3 or less, 3.1 wt% or less, or more, or less, or more, or less, or more, or less, or more, or less, or more, or less, or more, or less, or more, or less, or more, or less, or more, or less, or more, or less, 3% by weight or less, 2.9% by weight or less, 2.8% by weight or less, 2.7% by weight or less, 2.6% by weight or less, 2.5% by weight or less, 2.4% by weight or less, 2.3% by weight or less, 2.2% by weight or less, 2.1% by weight or less, or 2% by weight or less.
In one embodiment, the dietary fiber may contain one or more selected from the group consisting of citrus dietary fiber and wheat dietary fiber.
In one embodiment, the composition may contain 0.001 to 20% by weight of the dietary fiber, relative to the total weight of the composition. When the dietary fiber is contained in an amount exceeding 5% by weight, a large amount of foam is generated and the stability of the dosage form may be lowered. Specifically, the composition may contain 0.001 wt% or more, 0.002 wt% or more, 0.003 wt% or more, 0.005 wt% or more, 0.007 wt% or more, 0.01 wt% or more, 0.02 wt% or more, 0.03 wt% or more, 0.04 wt% or more, 0.05 wt% or more, 0.06 wt% or more, 0.07 wt% or more, 0.08 wt% or more, 0.09 wt% or more, 0.1 wt% or more, 0.2 wt% or more, 0.3 wt% or more, 0.4 wt% or more, or 0.5 wt% or more, and at the same time, 20 wt% or less, 19 wt% or less, 18 wt% or less, 17 wt% or less, 16 wt% or less, 15 wt% or less, 14 wt% or less, 13 wt% or less, 12 wt% or less, 11 wt% or less, 10 wt% or less, 9 wt% or less, 7 wt% or less, 6 wt% or less, 7 wt% or less, or less, 4.8% by weight or less, 4.6% by weight or less, 4.4% by weight or less, 4.2% by weight or less, 4% by weight or less, 3.8% by weight or less, 3.6% by weight or less, 3.4% by weight or less, 3.2% by weight or less, 3% by weight or less, 2.8% by weight or less, 2.6% by weight or less, 2.4% by weight or less, 2.2% by weight or less, or 2% by weight or less.
In one embodiment, the ginseng seed extract may be an extract of water, an organic solvent, or a mixed solvent thereof. The water may include distilled water or purified water, and the organic solvent may be ethanol, acetone, hexane, ethyl acetate, carbon dioxide, or a mixed organic solvent of two or more thereof, but is not limited thereto. The ethanol can be C1-C6Low concentration ethanol.
In one embodiment, the composition may be a liquid composition.
In one embodiment, the composition may be a food composition. The formulation of the food composition is not particularly limited, and for example, it may be formulated as tablets, granules, pills, liquid such as drinks, caramel, gel, bars, tea bags, and the like. The food composition of each dosage form can be formulated by appropriately selecting the ingredients generally used in the art, in addition to the effective ingredients, depending on the dosage form or the purpose of use, and can produce a synergistic effect when used together with other raw materials.
The food composition according to one embodiment may contain various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and accelerators (cheese, chocolate, etc.), pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, ethanol, carbonic acid agents used in carbonated beverages, and the like. In addition, the food composition according to an embodiment may contain natural fruit juice and pulp for preparing fruit juice beverages, vegetable beverages. These components may be used alone or in combination. The ratio of the additives is not critical, but generally ranges from 0 parts by weight to about 50 parts by weight for 100 parts by weight of the composition according to one embodiment.
In one embodiment, the composition may be a muscle energy metabolism-promoting composition.
In one embodiment, the composition may be a fat oxidation promoting composition.
In one embodiment, the composition can be a composition for mitochondrial augmentation and activation.
In one aspect, the present disclosure provides a capsule containing an emulsified composition. The capsule may be a soft or hard capsule.
In one aspect, the present disclosure provides a ginseng seed oil and use of a ginseng seed extract in the preparation of a composition for promoting muscle energy metabolism.
In one aspect, the present disclosure provides a ginseng seed oil and use of a ginseng seed extract in the preparation of a composition for fat oxidation.
In one aspect, the present disclosure provides a ginseng seed oil and use of a ginseng seed extract in the preparation of a composition for mitochondria augmentation and activation.
The present invention will be described in more detail below with reference to examples and the like. It should be clear to a person having ordinary knowledge in the art that the described embodiments are only intended to illustrate the invention and should not be construed as limiting the scope of the invention to the described embodiments.
[ PREPARATION EXAMPLE 1] preparation of ginseng seed oil
Harvesting fresh ginseng (Panax ginseng C.A. Meyer) seeds, separating out the seeds, and harvesting the ginseng seeds. Cleaning the harvested ginseng seeds, removing foreign matters, and screening only the seeds which can be squeezed. Drying, pulverizing, removing impurities, squeezing in oil press (DS-1500, DASAN food industry apparatus, Korea) to obtain Ginseng radix seed oil stock solution. Purifying the extracted ginseng seed oil stock solution, and filtering to obtain the ginseng seed oil.
[ PREPARATION EXAMPLE 2] preparation of Ginseng seed extract
Mixing pulp and fruit juice of fresh radix Ginseng (Panax ginseng C.A. Meyer) seed without peel to obtain radix Ginseng seed material. To 1kg of the ginseng seed material prepared as above, 3L of ethanol was added, and after reflux extraction at 25 ℃ for 4 hours, the ginseng seed extract was obtained by concentration under reduced pressure.
[ PREPARATION EXAMPLE 3] preparation of Red Ginseng extract
1kg of red ginseng material was put into an extractor, and 3L of water and ethanol mixed in a volume ratio of 1:1 were added to the extractor. The extraction was repeated 4 times at 70 ℃ for 10 hours, and the extract was subjected to pressure filtration using a 250 mesh filter. Transferring the liquid into a vacuum concentrator, concentrating at 70 deg.C under 600mmHg, transferring into a sterilizing tank, and steam sterilizing at 83 deg.C for 20 min to obtain Ginseng radix Rubri extract.
[ example 1]
Example 1 was prepared as an emulsified composition of ginseng seed oil and ginseng seed extract according to the components of table 1 below. Specifically, the ginseng seed oil of preparation example 1 was added to the ginseng seed extract of preparation example 2, heated to 70 ℃, and stirred at 200rpm using an Agi mixer. Example 1 was prepared by adding a solution of ginseng seed oil stirred with a ginseng seed extract to purified water and stirring at 200rpm using an Agi mixer (or homogenizer) at 80 ℃.
[ Table 1]
(unit: wt%) | Example 1 | Example 2 | Comparative example 1 | Comparative example 2 |
Ginseng seed oil | 2.5 | 2.5 | 2.5 | 2.5 |
Ginseng seed extract | 25 | 25 | - | - |
Ginseng radix Rubri extract | - | - | 25 | 25 |
Gellan gum | - | 0.1 | - | 0.1 |
Citrus reticulata dietary fiber | - | 0.4 | - | 0.4 |
Purified water | To 100 | To 100 | To 100 | To 100 |
Total up to | 100 | 100 | 100 | 100 |
[ example 2]
Example 2 was prepared as an emulsified composition of ginseng seed oil and ginseng seed extract containing gellan gum and dietary fiber according to the components of table 1 above. Specifically, the ginseng seed oil of preparation example 1 was added to the ginseng seed extract of preparation example 2, heated to 70 ℃, and stirred at 200rpm using an Agi mixer. Adding gellan gum and citrus dietary fiber into purified water, and heating to 80 deg.C to hydrate gellan gum and citrus dietary fiber. Then, a solution in which ginseng seed oil was stirred to the ginseng seed extract was added to purified water in which gellan gum and dietary fiber were hydrated and reacted, and stirred at 200rpm using an Agi mixer at 80 ℃ to prepare example 2.
Comparative example 1
The composition of comparative example 1 was prepared according to the components of table 1 above. Specifically, the ginseng seed oil of preparation example 1 was added to the red ginseng extract of preparation example 3, and the mixture was heated to 70 ℃ and stirred at 200rpm using an Agi mixer. To the purified water was added a solution of ginseng seed oil stirred with the ginseng seed extract, and stirred at 80 ℃ with an Agi mixer at 200rpm to prepare comparative example 1.
Comparative example 2
The composition of comparative example 2 containing gellan gum and dietary fiber was prepared according to the components of table 1 above. Specifically, the ginseng seed oil of preparation example 1 was added to the red ginseng extract of preparation example 3, and the mixture was heated to 70 ℃ and stirred at 200rpm using an Agi mixer. Adding gellan gum and citrus dietary fiber into purified water, and heating to 80 deg.C to hydrate gellan gum and citrus dietary fiber. Then, a solution in which ginseng seed oil was stirred to the ginseng seed extract was added to purified water in which gellan gum and dietary fiber were hydrated, and stirred at 200rpm using an Agi mixer at 80 ℃ to prepare comparative example 2.
Experimental example 1 confirmation of emulsion stability
The results of mixing immediately after examples 1 and 2 and comparative examples 1 and 2 were confirmed, and after standing at 25 ℃ for 24 hours, the mixture was stirred again for 10 seconds to confirm whether or not the oil phase and the water phase were separated, and the results are shown in table 2, fig. 1, and fig. 2.
[ Table 2]
Example 1 | Example 2 | Comparative example 1 | Comparative example 2 | |
Just after preparation | Mixing uniformly | Mixing uniformly | Oil phase separation | Generating a large amount of foam |
Standing for 24 hours | Maintaining uniformity | Maintaining uniformity | Oil phase separation | Generating a large amount of foam |
As confirmed from the results of table 2, fig. 1 and fig. 2, the examples 1 and 2, which contained ginseng seed oil and ginseng seed extract, were confirmed to have a single phase, in which the oil components were uniformly mixed and maintained stable uniformity even after 24 hours. In contrast, in comparative example 1 and comparative example 2 containing ginseng seed oil and red ginseng extract, the oil component and the water-soluble component were not uniformly mixed, but the oil phase was separated, and in comparative example 2 containing gellan gum, it was confirmed that a large amount of foam was generated instead.
[ Experimental example 2] measurement of the absorption amount of ginsenoside
In order to measure the amount of ginsenoside absorbed, example 1, comparative example 1, the ginseng seed extract (prepared example 2 diluted 4 times with purified water) and the red ginseng extract (prepared example 3 diluted 4 times with purified water) were each passed through a human digestion simulation system, and then the amount of ginsenoside transferred to Caco-2 cells (ATCC) taken from human intestinal cells was measured. Specifically, in the saliva step (salivar phase) of the human digestion simulation system, amylase (2ml) was added to the samples (example 1, comparative example 1, ginseng seed extract, red ginseng extract), followed by stirring at 100rpm for 3 minutes at 37 ℃ and pH6.9, and then in the stomach step (gastrotic phase), pepsin (4ml) was added to the samples passed through the saliva step, followed by stirring at 100rpm for 1 hour at 37 ℃ and pH2(1M HCl), followed by digestion. Then, as a Small intestinal step (Small intestinal phase), lipase, pancreatin, bile acid (bile acid), and amyloglucosidase (amyloglucosidase) were added to the sample digested in the above step, and then the mixture was treated at 37 ℃ and pH5.3(1M NaHCO) to obtain a Small intestinal sample3) Next, the mixture was stirred at 100rpm for 2 hours. As described above, the sample passed through the human digestion simulation system was centrifuged, the supernatant was diluted 10 times to DMEM, and the processed DMEM was used5% CO at 37 ℃ in a trans well2Caco-2 cells were cultured for 2 hours under the conditions of (1). After the cultured Caco-2 cells were recovered, the amount of ginsenoside absorbed by Caco-2 cells was measured by High Performance Liquid Chromatography (HPLC), and the results are shown in Table 3 below.
[ Table 3]
As confirmed from the results in table 3, it was found that example 1 containing ginseng seed oil and ginseng seed extract was excellent in the content of ginsenoside absorbed by small intestinal cells and the dosage form stability.
[ Experimental example 3] measurement of expression of genes involved in energy metabolism based on addition of ginseng seed oil
DMEM (Dulbecco' S Modified Essential Medium; Sigma Aldrich) supplemented with 10% fetal bovine serum (total bovine serum; Hyclone), 1% penicillin/streptomycin (penicillin/streptomycin; P/S; Sigma Aldrich) at 5% CO was used2Myoblasts (myoblasts) obtained from rats purchased from ATCC company were cultured in an incubator (incubator) at 37 ℃. When the number of myoblasts in the Plate (Plate) reached 100%, myotube cells (myotube) were generated by differentiation for one week by a serum starvation (DMEM supplemented with 2% horse serum (Hyclone) and 1% P/S). In myotube cells that completed differentiation, the ginseng seed oil (GS0) of preparation example 1, the ginseng seed extract (GB) of preparation example 2, and the red ginseng extract (RG) of preparation example 3 were treated individually (100ug/ml) or in combination (100. mu.g/ml for each sample and 200. mu.g/ml for the sum of samples) for 16 hours. The positive control group used fenofibrate (100 μ M)) as a PPAR α agonist (agonst) that promotes muscle energy metabolism.
Then, RNA was extracted from myotube cells treated with the above-described sample using a kit (Trizol agent; Invitrogen corporation), and cDNA was synthesized using a RevertAID first strand cDNA Synthesis kit (RevertAID 1st strand cDNA Synthesis kit). Q-PCR (quantitative real-time polymerase chain reaction) was analyzed using CFX96 thermal cycler (thermocycler) of Bio-Rad company, and genes related to energy metabolism (tissue long-chain Acyl-CoA Oxidase (Acyl-CoA Oxidase; ACO), Carnitine-lipid acyltransferase-1 (Carnitine-lipid transferase 1; CPT1), Peroxisome Proliferator-activated Receptor alpha (Peroxisome Proliferator-activated Receptor alpha; PPAR alpha), gamma PPAR co-activated factor 1 alpha (PPAR gamma-coactivator 1 alpha; PGC1 alpha), transcription factor a mitochondria (transcription factor a mitochondria; tfam), uncoupling protein 3 (monoclonal protein 3; P3)) were compared based on the expression level of cyclophilin (cyclophilin) and the relative expression level of RG 3 (RG 3A to RG 3) is shown in the graph, and FIG. 3 shows the relative expression level of RG 3A to RG 3G 3B seed oil, and FIG. 3 shows the relative expression level of RG 3A seed oil, fano stands for fenofibrate).
As shown in fig. 3A to 3F, it was confirmed that the ginseng seed extract has high fat oxidation and expression levels of mitochondrial-related genes relative to the red ginseng extract, and the ginseng seed oil has no particular effect on lipid metabolism in muscle cells. In addition, it was confirmed that the red ginseng extract and the ginseng seed oil showed a synergistic effect, and the gene expression of the red ginseng extract was increased by about 20 to 30% by adding the ginseng seed oil, whereas the ginseng seed extract showed an increasing effect of about 30 to 50% by adding the ginseng seed oil to the ginseng seed extract. Thus, it was confirmed that the ginseng seed oil doubles the energy metabolism promoting effect of the red ginseng extract and the ginseng seed extract, and the synergistic effect is more significant in the ginseng seed extract than in the red ginseng extract. In addition, no increase in energy metabolism based on the treatment of ginseng seed oil was observed in the fenofibrate (fenofibrate) treated group, so that it can be understood that the energy metabolism promoting synergistic effect of ginseng seed oil was specifically shown in red ginseng as well as ginseng seeds.
[ Experimental example 4] based on the increase of ginseng seed oil, increase of mitochondria in myocyte was observed
After treating a sample with the same conditions for myocytes differentiated by the same method as in experimental example 4, the sample was washed 2 times with PBS, and the residual medium was removed. Then, the muscle cells were treated with a mitochondrial Green fluorescent probe (Mitotrack Green FM; Invitrogen corporation) for 30 minutes to stain mitochondria. After 3 additional PBS washing operations, the cells were fixed with formaldehyde (formaldehyde; sigma Aldrich) and observed by a fluorescence microscope (EVOS M5000), and shown in fig. 4A and 4B (in fig. 4A and 4B, GSO represents ginseng seed oil, GB represents ginseng seed extract, RG represents red ginseng extract, and Fano represents fenofibrate).
As shown in fig. 4A and 4B, the phenomenon of increased mitochondria resulting from the treatment of ginseng seed extract was more significant than that of the red ginseng extract treated group, as in the case of increased expression of mitochondrial generation-related genes (PGC1 α, tfam) measured in experimental example 3. In particular, it was observed that in the group in which the ginseng seed extract and the ginseng seed oil were treated together, the mitochondrial density increased to a similar extent to the positive control (fenofibrate) result, and thus it was expected that the ginseng seed oil could actually promote the energy metabolism in the muscle cells.
Formulation example 1 health drink
A healthy beverage was prepared by a general method according to the components described in the following table 4.
[ Table 4]
Formulation of ingredients | Content (wt.) |
Ginseng seed oil | 2g |
Ginseng seed extract | 20g |
Gellan gum | 0.1g |
Vitamin A acetate | 70μg |
Vitamin E | 1mg |
Vitamin B1 | 0.13mg |
Vitamin B2 | 0.15mg |
Vitamin B6 | 0.5mg |
Vitamin B12 | 0.2μg |
Vitamin C | 10mg |
Biotin | 10μg |
Oligosaccharides | 2.5g |
Purified water | 125ml |
The ingredients are mixed according to a method generally used for preparing a health drink, and after stirring at 80 ℃ for about 1 hour, the resulting solution is filtered and sterilized.
[ dosage form example 2] Soft Capsule
Mixing 50mg of ginseng seed oil, 320mg of ginseng seed extract, 60mg of L-carnitine, 2mg of palm oil, 8mg of vegetable hydrogenated oil, 4mg of yellow beeswax and 6mg of soft phospholipid, and filling 1 capsule according to a conventional method to prepare a soft capsule.
Formulation example 3 liquid
A liquid preparation was prepared by mixing 2g of ginseng seed oil, 25g of ginseng seed extract, 3g of isomerized sugar, 1g of mannitol, and 70ml of purified water according to a conventional method for preparing a liquid preparation, filling the mixture in a brown bottle, and sterilizing the bottle.
[ formulation example 4] drink preparation
After 10g of ginseng seed oil, 100g of ginseng seed extract, 10g of glucose, 0.6g of citric acid and 25g of liquid oligosaccharide were mixed, 500ml of purified water was added, and 200ml of each bottle was filled. And (3) after filling the mixture into a bottle, sterilizing the mixture at 130 ℃ for 4-5 seconds, and preparing the beverage.
This application claims priority from korean patent application No. 10-2020-0039315, filed 3/31/2020, which is hereby incorporated by reference in its entirety.
Claims (11)
1. An emulsified composition comprises ginseng seed oil and ginseng seed extract.
2. The emulsified composition according to claim 1,
the ginseng includes one or more selected from the group consisting of Korean ginseng (Panax ginseng), American ginseng (Panax quinquefolia), Panax notoginseng (Panax notogeng), Vietnamese ginseng (Panax vietnamensis), Panax japonicus (Panax japonica), Panax elegans (Panax elegator), Panax quinquefolium (Panax wangianus), Panax notoginseng (Panax bipinnatifidus) and Panax pseudoginseng (Panax pseudoginseng).
3. The emulsified composition according to claim 1,
the Ginseng radix extract is water, C1-C6Ethanol or a mixed solvent thereof.
4. The emulsified composition according to claim 1,
the composition comprises 0.001 wt% to 70 wt% of the ginseng seed oil relative to the total weight of the composition.
5. The emulsified composition according to claim 1,
the composition comprises 0.01 wt% to 60 wt% of the ginseng seed extract relative to the total weight of the composition.
6. The emulsified composition according to claim 1,
the weight ratio of the ginseng seed oil to the ginseng seed extract is 1:2 to 1: 100.
7. The emulsified composition according to claim 1,
the composition also contains viscose and dietary fiber.
8. The emulsified composition according to claim 7,
the viscose comprises at least one selected from the group consisting of Xanthan gum (Xanthan gum), carrageenan (Carrageenans gum), Guar gum (Guar gum), Gellan gum (Gellan gum), Locust Bean gum (locusts Bean gum), Tamarind gum (Tamarind gum), Arabic gum (Arabic gum), konjac, pectin, agar, tapioca starch, dextrin, Hydroxypropylmethylcellulose (HPMC), sodium alginate and modified starch.
9. The emulsified composition according to claim 7,
the dietary fiber contains at least one selected from the group consisting of citrus dietary fiber and wheat dietary fiber.
10. The emulsion composition according to any one of claims 1 to 9, wherein,
the composition is a liquid composition.
11. The emulsion composition according to any one of claims 1 to 9, wherein,
the composition is a food composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2020-0039315 | 2020-03-31 | ||
KR1020200039315A KR20210121892A (en) | 2020-03-31 | 2020-03-31 | Composition comprising ginseng seed oil |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113455656A true CN113455656A (en) | 2021-10-01 |
Family
ID=77854960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110338259.7A Pending CN113455656A (en) | 2020-03-31 | 2021-03-30 | Emulsified composition |
Country Status (4)
Country | Link |
---|---|
US (1) | US11717012B2 (en) |
JP (1) | JP2021159078A (en) |
KR (1) | KR20210121892A (en) |
CN (1) | CN113455656A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4159549B1 (en) | 2021-09-29 | 2023-10-25 | Toyoda Gosei Co., Ltd. | Occupant protection device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103479538A (en) * | 2008-06-13 | 2014-01-01 | 株式会社爱茉莉太平洋 | External preparation composition for skin comprising ginseng flower or ginseng seed extracts |
KR20160134375A (en) * | 2015-05-15 | 2016-11-23 | 주식회사 네이처텍 | Water soluble composition comprising ginseng seed oil |
CN110787075A (en) * | 2019-11-23 | 2020-02-14 | 吉林省丽芙泉生物科技有限公司 | A skin care oil composition containing Ginseng radix extract and Ginseng radix seed oil |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1217932A (en) * | 1997-11-24 | 1999-06-02 | 集安市新开河参业有限公司 | Anti-primordial oral liquid |
US6524626B2 (en) | 1999-04-23 | 2003-02-25 | E Excel International, Inc. | Ginseng berry topical products |
KR20130090029A (en) | 2012-02-03 | 2013-08-13 | 이현기 | Manufacturing method of skin external and skin external composition mainly with steamed ginseng seeds using the same |
KR101910865B1 (en) | 2012-07-06 | 2018-10-23 | (주)아모레퍼시픽 | External composition for skin containing germinated seeds of ginseng extract |
KR102273966B1 (en) | 2014-10-17 | 2021-07-08 | (주)아모레퍼시픽 | Agent for Masking Bitterness of Ginseng and Ginseng Composition Containing the Same |
KR102273967B1 (en) * | 2014-10-31 | 2021-07-08 | (주)아모레퍼시픽 | Composition for preventing and treating prostatic hypertrophy containing ginseng seed oil |
KR20180092599A (en) | 2017-02-10 | 2018-08-20 | 남춘옥 | Cosmetic composition using wild ginseng |
KR101924446B1 (en) | 2017-12-20 | 2018-12-03 | (주)아모레퍼시픽 | Composition containing ginseng berry extract using processing of herbal medicine |
KR102613550B1 (en) | 2018-05-17 | 2023-12-14 | 한국생명공학연구원 | A ginsenoside complex comprising insoluble substance curcumin |
-
2020
- 2020-03-31 KR KR1020200039315A patent/KR20210121892A/en active Search and Examination
-
2021
- 2021-03-23 JP JP2021049193A patent/JP2021159078A/en active Pending
- 2021-03-30 CN CN202110338259.7A patent/CN113455656A/en active Pending
- 2021-03-30 US US17/217,809 patent/US11717012B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103479538A (en) * | 2008-06-13 | 2014-01-01 | 株式会社爱茉莉太平洋 | External preparation composition for skin comprising ginseng flower or ginseng seed extracts |
KR20160134375A (en) * | 2015-05-15 | 2016-11-23 | 주식회사 네이처텍 | Water soluble composition comprising ginseng seed oil |
CN110787075A (en) * | 2019-11-23 | 2020-02-14 | 吉林省丽芙泉生物科技有限公司 | A skin care oil composition containing Ginseng radix extract and Ginseng radix seed oil |
Also Published As
Publication number | Publication date |
---|---|
JP2021159078A (en) | 2021-10-11 |
US11717012B2 (en) | 2023-08-08 |
US20210298339A1 (en) | 2021-09-30 |
KR20210121892A (en) | 2021-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100563668C (en) | Use the gen-seng and the processing thereof of vinegar | |
EP3017821B1 (en) | Composition having a function for alleviating premenstrual syndrome and menstrual pain | |
CN1646150A (en) | Novel use of the extract of processed ginseng and saponin isolated therefrom | |
EP2711014A2 (en) | Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis | |
US8168237B2 (en) | Medicinal herbal extract having anti-obesity effect | |
KR20160013731A (en) | Preparation method of ginseng fermentation product enhanced ginsenoside Rh2 and Rg3 content | |
CN113455656A (en) | Emulsified composition | |
KR101253658B1 (en) | Manufacturing method of treated puffing and fermentation red ginseng concentrate | |
CN111592959A (en) | Tonic three-penis wine and extraction method thereof | |
CN101884408B (en) | Ginkgo leaf leaching liquor and preparation method thereof | |
KR20130074119A (en) | Ginseng prosapogenin high concentration containing ginseng leaf or stem preparation using sonication and process for thereof | |
KR100994196B1 (en) | Method of preparing fermented liquid of garlic and chonggugjang | |
KR20150051811A (en) | Composition containing ginseng extract and ginseng fruit extract | |
CN111264654B (en) | Preparation method of black tea flavor instant powder | |
KR20130074118A (en) | Ginseng prosapogenin high concentration containing ginseng berry preparation using sonication and process for thereof | |
KR101910099B1 (en) | Compositions for improving lipid metabolism or anti-obesity as an active ingredient extracted from an immature persimmon by pressurized hydrothermal method | |
KR20210043273A (en) | Liquid tea containing fermented mountain-cultivated ginseng and preparation method thereof | |
JP6924486B2 (en) | Food composition | |
JP6261798B1 (en) | Food composition | |
CN106108020A (en) | A kind of ginkgo nut nutritive powder and application thereof | |
KR101487598B1 (en) | Composition for preventing hair loss and growing hair using fraction of unripe astringent persimmon | |
CN112143609A (en) | Tonic and nutritious three-penis wine and its extraction method | |
JP2015189738A (en) | Skin condition improving agents | |
CN117204527A (en) | Whole-plant fresh pseudo-ginseng wall-broken original pulp oral liquid and preparation method thereof | |
CN113892569A (en) | Composite beverage and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40050691 Country of ref document: HK |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |